2018 | Bryan Williams* (ESC Chairperson) (UK), Giuseppe Mancia* (ESH Chairperson) (Italy), Wilko Spiering (The Netherlands), Enrico Agabiti Rosei (Italy), Michel Azizi (France), Michel Burnier (Switzerland), Denis L. Clement (Belgium), Antonio Coca (Spain), Giovanni de Simone (Italy), Anna Dominiczak (UK), Thomas Kahan (Sweden), Felix Mahfoud (Germany), Josep Redon (Spain), Luis Ruilope (Spain), Alberto Zanchetti† (Italy), Mary Kerins (Ireland), Sverre E. Kjeldsen (Norway), Reinhold Kreutz (Germany), Stephane Laurent (France), Gregory Y. H. Lip (UK), Richard McManus (UK), Krzysztof Narkiewicz (Poland), Frank Ruschitzka (Switzerland), Roland E. Schmieder (Germany), Evgeny Shlyakhto (Russia), Costas Tsioufis (Greece), Victor Aboyans (France), and Ileana Desormais (France)
The 2018 ESC/ESH Guidelines for the management of arterial hypertension were developed by the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). The guidelines aim to provide evidence-based recommendations for the diagnosis, treatment, and management of hypertension. The Task Force, consisting of experts from both societies, reviewed the latest scientific evidence and developed recommendations based on randomized controlled trials (RCTs) and other high-quality studies. The guidelines emphasize the importance of identifying and managing hypertension-mediated organ damage, which is a key factor in cardiovascular risk assessment. They also provide detailed recommendations on blood pressure measurement, treatment targets, and the use of lifestyle and drug therapies. The guidelines highlight the importance of individualized treatment, considering factors such as age, comorbidities, and the patient's overall cardiovascular risk. The guidelines also address specific populations, including older adults, women, and patients with diabetes or chronic kidney disease. The recommendations are based on a systematic review of the literature and are intended to assist healthcare professionals in making informed decisions about the management of hypertension. The guidelines are available on the ESC website and are regularly updated to reflect new evidence and developments in the field of hypertension management.The 2018 ESC/ESH Guidelines for the management of arterial hypertension were developed by the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). The guidelines aim to provide evidence-based recommendations for the diagnosis, treatment, and management of hypertension. The Task Force, consisting of experts from both societies, reviewed the latest scientific evidence and developed recommendations based on randomized controlled trials (RCTs) and other high-quality studies. The guidelines emphasize the importance of identifying and managing hypertension-mediated organ damage, which is a key factor in cardiovascular risk assessment. They also provide detailed recommendations on blood pressure measurement, treatment targets, and the use of lifestyle and drug therapies. The guidelines highlight the importance of individualized treatment, considering factors such as age, comorbidities, and the patient's overall cardiovascular risk. The guidelines also address specific populations, including older adults, women, and patients with diabetes or chronic kidney disease. The recommendations are based on a systematic review of the literature and are intended to assist healthcare professionals in making informed decisions about the management of hypertension. The guidelines are available on the ESC website and are regularly updated to reflect new evidence and developments in the field of hypertension management.